194 related articles for article (PubMed ID: 16044883)
1. MMA formulary design requires health plans to control costs.
Sipkoff M
Manag Care; 2005 Jun; 14(6):18, 20. PubMed ID: 16044883
[No Abstract] [Full Text] [Related]
2. Assessing Medicare prescription drug plans in four states: balancing cost and access.
Heaton E; Carino T; Dix H
Issue Brief (Commonw Fund); 2006 Aug; 22():1-14. PubMed ID: 16933399
[TBL] [Abstract][Full Text] [Related]
3. Can private Medicare health plans effectively compete with the government?
Twiss AK
Manag Care Interface; 2004 May; 17(5):25-6, 32. PubMed ID: 15217161
[No Abstract] [Full Text] [Related]
4. Access to cancer drugs in Medicare Part D: formulary placement and beneficiary cost sharing in 2006.
Bowman J; Rousseau A; Silk D; Harrison C
Health Aff (Millwood); 2006; 25(5):1240-8. PubMed ID: 16966719
[TBL] [Abstract][Full Text] [Related]
5. Pharmaceutical formularies: the right formula for cost and utilization?
Austin B
Find Brief; 2004 Aug; 7(5):1-3. PubMed ID: 15298009
[No Abstract] [Full Text] [Related]
6. Strategies for developing a successful Medicare part D formulary.
Stefanacci RG
Manag Care; 2005 May; 14(5 Suppl):3-10. PubMed ID: 15962831
[No Abstract] [Full Text] [Related]
7. The formulary files. ARB costs run high in Medicare part D.
Manag Care; 2007 Aug; 16(8):48. PubMed ID: 17886540
[No Abstract] [Full Text] [Related]
8. A first look at the new Medicare prescription drug plans.
Frakt AB; Pizer SD
Health Aff (Millwood); 2006; 25(4):W252-61. PubMed ID: 16720588
[TBL] [Abstract][Full Text] [Related]
9. Prescription drug formulary design, preferred-product marketshare, and formulary noncompliance: a study of proton-pump inhibitors.
Wang YR; Pauly MV
Manag Care Interface; 2005 Aug; 18(8):39-45. PubMed ID: 16127891
[TBL] [Abstract][Full Text] [Related]
10. Plans, PBMs, pharmacy jockey for part D positioning. Are pharmacies raising rates for health plans?
Med Health; 2005 Jun; 59(20):1-2. PubMed ID: 16021969
[No Abstract] [Full Text] [Related]
11. PBMs to the rescue? Pharmacy benefit managers will play a key role in the Medicare drug benefit. What does it mean for the industry, consumers and Uncle Sam?
Fong T
Mod Healthc; 2005 Nov; 35(48):26-8, 30. PubMed ID: 16617721
[No Abstract] [Full Text] [Related]
12. It's that time of year again. Seniors can now switch Medicare drug plans.
Andrews M
US News World Rep; 2006 Nov; 141(20):68. PubMed ID: 17153489
[No Abstract] [Full Text] [Related]
13. Pharmaceuticals: Medicare Modernization Act--2005. End of Year Issue Brief.
Seay M
Issue Brief Health Policy Track Serv; 2005 Dec; ():1-21. PubMed ID: 16710928
[TBL] [Abstract][Full Text] [Related]
14. HCFA's intermediaries told to cut their costs.
Robinson ML
Mod Healthc; 1981 Sep; 11(9):22. PubMed ID: 10298262
[No Abstract] [Full Text] [Related]
15. Medicare prescription drug plans: the impact on physician practice.
Marable S
Med Health R I; 2006 Jan; 89(1):39-40. PubMed ID: 16519205
[No Abstract] [Full Text] [Related]
16. Bad tiered formulary designs yield poor outcomes, high cost.
Sipkoff M
Manag Care; 2004 Aug; 13(8):27, 31-2, 34-5. PubMed ID: 15457893
[No Abstract] [Full Text] [Related]
17. Grassley, CMS: USP classes won't get formulary a free pass.
Med Health; 2004 Oct; 58(36):3-4. PubMed ID: 15499734
[No Abstract] [Full Text] [Related]
18. What you need to know about Medicare Part D.
Consum Rep; 2006 Feb; 71(2):34-6. PubMed ID: 16509047
[No Abstract] [Full Text] [Related]
19. Prediction of Medicare drug formulary drugs for treatment of overactive bladder.
Grocela JA; Kanji A; Ternullo J
J Urol; 2006 Jul; 176(1):252-5; discussion 255-6. PubMed ID: 16753413
[TBL] [Abstract][Full Text] [Related]
20. Medicare formulary model seen by many as too inclusive.
Carroll J
Manag Care; 2004 Nov; 13(11):10, 12. PubMed ID: 15595394
[No Abstract] [Full Text] [Related]
[Next] [New Search]
